The novel treatment of tirzepatide peptide represents a significant breakthrough in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – resulting in greater glucose regulation and possible weight reduction. Scientists are exploring its long-ter